Manufacturing companies increasingly become "smarter" as a result of the Industry 4.0 revolution. Multiple sensors are used for industrial monitoring of machines and workers in order to detect events and consequently improve the manufacturing processes, lower the respective costs, and increase safety. Multisensor systems produce big amounts of heterogeneous data. Data fusion techniques address the issue of multimodality by combining data from different sources and improving the results of monitoring systems. The current paper presents a detailed review of state-of-the-art data fusion solutions, on data storage and indexing from various types of sensors, feature engineering, and multimodal data integration. The review aims to serve as a guide for the early stages of an analytic pipeline of manufacturing prognosis. The reviewed literature showed that in fusion and in preprocessing, the methods chosen to be applied in this sector are beyond the state-of-the-art. Existing weaknesses and gaps that lead to future research goals were also identified.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914726 | PMC |
http://dx.doi.org/10.3390/s22051734 | DOI Listing |
Microsc Res Tech
January 2025
School of Computer Science, Hubei University of Technology, Wuhan, China.
Reactive lymphocytes are an important type of leukocytes, which are morphologically transformed from lymphocytes. The increase in these cells is usually a sign of certain virus infections, so their detection plays an important role in the fight against diseases. Manual detection of reactive lymphocytes is undoubtedly time-consuming and labor-intensive, requiring a high level of professional knowledge.
View Article and Find Full Text PDFTher Adv Med Oncol
January 2025
Statistical Sciences, Eli Lilly and Company, Shanghai, China.
Background: Selpercatinib is approved for the treatment of -fusion-positive non-small-cell lung cancer (NSCLC).
Objective: We present a final update on LIBRETTO-321 to enhance the understanding of long-term efficacy and safety in Chinese patients.
Design: This open-label, multicenter, phase II study included patients with advanced -altered solid tumors.
JACC Adv
January 2025
Department of Radiology, Mayo Clinic, Phoenix, Arizona, USA.
Background: Immune checkpoint inhibitor (ICI) therapy has dramatically improved the prognosis for some cancers but can be associated with myocarditis, adverse cardiovascular events, and mortality.
Objectives: The aim of this study was to develop an artificial intelligence (AI) model to predict the increased likelihood for the development of ICI-related myocarditis and adverse cardiovascular events.
Methods: Cancer patients treated with ICI at a tertiary institution from 2011 to 2022 were reviewed.
Front Plant Sci
December 2024
School of Surveying and Land Information Engineering, Henan Polytechnic University, Jiaozuo, China.
Introduction: In the context of climate variability, rapid and accurate estimation of winter wheat yield is essential for agricultural policymaking and food security. With advancements in remote sensing technology and deep learning, methods utilizing remotely sensed data are increasingly being employed for large-scale crop growth monitoring and yield estimation.
Methods: Solar-induced chlorophyll fluorescence (SIF) is a new remote sensing metric that is closely linked to crop photosynthesis and has been applied to crop growth and drought monitoring.
N Am Spine Soc J
December 2024
Research Department, Hartford HealthCare Bone and Joint Institute, Hartford, CT, United States of America.
Background: Prospective, longitudinal collection of patients reported outcomes (PRO) has become an essential metric in orthopedics. Despite the utility of PROs, data collection presents a significant challenge to the healthcare system. There is a need to better understand if serial data collection over a 1 to 2 year postoperative period is truly warranted.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!